Some 79 percent of the patients receiving the new combination of cefepime and enmetazobactam were successfully treated for their illness, as opposed to 58.9 percent of those receiving the conventional treatment of piperacillin and tazobactam.
from Zee News :Zee News - Health https://ift.tt/IMmyUOX
via IFTTT
Subscribe to:
Post Comments (Atom)
How India’s Love For Tea-Time Treats Is Raising Diabetes Risk?
Tea itself isn’t the problem it is the habitual pairing with high-sugar, high-salt, and high-fat snacks. With India witnessing rising diabet...
-
A new study by CMC Vellore highlights the alarming rise of scrub typhus in rural areas, emphasizing the need for better diagnosis and awaren...
-
A new diet trend called the 'Switch On' diet is taking social media by storm after a woman claimed to have lost 4 kg in just 6 days ...
No comments:
Post a Comment